Ardent Health shareholders elect 11 directors and approve say-on-pay at 2026 annual meeting

Ardent Health, Inc.

All 11 director nominees elected with strong support; Mark Sotir received 90.7M for, 861K withhold.
Advisory say-on-pay passed with 91.1M for, 300.7K against, and 184.5K abstentions.
Ratification of Ernst & Young as auditor approved with 97.9M for, 918K against, and 7.8K abstentions.
Broker non-votes were 7.2M for director elections and say-on-pay, none for auditor ratification.
Approximately 98.8M of 143.1M outstanding shares were voted (69% turnout).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Ardent Health, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-20 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-20

Exact text from the filing

The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: For Against Abstentions Broker Non-Votes 97,852,830 918,233 7,763 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Ardent Health, Inc. shareholders approved Advisory vote on executive compensation at the 2026-05-20 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-05-20

Exact text from the filing

The stockholders approved on a non-binding advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026, as follows: For Against Abstentions Broker Non-Votes 91,093,535 300,746 184,475 7,200,070

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Ardent Health, Inc. shareholders approved Election of 11 director nominees at the 2026-05-20 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-20

Exact text from the filing

The following 11 director nominees were elected to the Company's Board of Directors, as follows: For Withhold Broker Non-Votes Mark Sotir 90,717,572 861,184 7,200,070 Martin J. Bonick 91,240,732 338,024 7,200,070 Peter Bulgarelli 91,267,887 310,869 7,200,070 Peter Bynoe 87,141,918 4,436,838 7,200,070 Suzanne Campion 91,271,694 307,062 7,200,070 Robert A. DeMichiei 91,243,922 334,834 7,200,070 William Goodyear 91,243,902 334,854 7,200,070 Ellen Havdala 86,273,698 5,305,058 7,200,070 Edmondo Robinson 91,328,193 250,563 7,200,070 Rahul Sen 79,335,440 12,243,316 7,200,070 Rob Webb 91,362,871 215,885 7,200,070

View on SEC.gov

Browse all shareholder votes →

Ardent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-038152

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.